Advertisement | | Are you using the right delivery system?
Viruses are exceptionally powerful tools for overexpressing, silencing, and editing genes. However, it is important to know which tool is right for the job. Read our Viral Delivery Guide to find out which virus will work best for your experiments. | | | | | |
TABLE OF CONTENTS | | | | Volume 25, Issue 8 | | In this issue Article Announcement Also new AOP
| | | | | Article | | | Long noncoding RNA Meg3 regulates cardiomyocyte apoptosis in myocardial infarction Hongchun Wu, Zhen-Ao Zhao, Junwei Liu, Kaili Hao, You Yu et al. Gene Therapy 2018 25 :511 - 523; October 04, 2018; 10.1038/s41434-018-0045-4 Abstract | Full Text | | | | | Epistasis between Pax6Sey and genetic background reinforces the value of defined hybrid mouse models for therapeutic trials Jack W. Hickmott, Uvini Gunawardane, Kimberly Jensen, Andrea J. Korecki & Elizabeth M. Simpson Gene Therapy 2018 25 :524 - 537; September 26, 2018; 10.1038/s41434-018-0043-6 Abstract | Full Text | | | | | Improved therapeutic potential of MSCs by genetic modification Wei Wei, Yong Huang, Dan Li, Hong-Feng Gou & Wei Wang Gene Therapy 2018 25 :538 - 547; September 25, 2018; 10.1038/s41434-018-0041-8 Abstract | Full Text | | | | | Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model Anna Egorova, Mariya Petrosyan, Marianna Maretina, Natalia Balashova, Lyudmila Polyanskih et al. Gene Therapy 2018 25 :548 - 555; September 25, 2018; 10.1038/s41434-018-0042-7 Abstract | Full Text | | | | | Scaffold-mediated delivery for non-viral mRNA vaccines Ruying Chen, Hong Zhang, Jingxuan Yan & James D. Bryers Gene Therapy 2018 25 :556 - 567; September 21, 2018; 10.1038/s41434-018-0040-9 Abstract | Full Text | | Announcement | | | Reviewer recognition Gene Therapy 2018 25 :568 - 571; December 03, 2018; 10.1038/s41434-018-0048-1 Abstract | Full Text | | Advertisement | | Focal Point on Vaccine Research
The future of vaccine research may be in Asia
The signs are there in funding levels, and combined with Asian governments' interest in biotechnology, and a highly skilled, highly educated workforce, pharma giants are looking east. | | | | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from Gene Therapy click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved. | | | |
No comments:
Post a Comment